Lipitor and Dimetapp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Dimetapp (brompheniramine maleate; phenylpropanolamine hydrochloride). Common drug interactions include cerebrovascular accident among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Dimetapp. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Dimetapp?

Dimetapp has active ingredients of brompheniramine maleate; phenylpropanolamine hydrochloride. It is often used in cough. eHealthMe is studying from 4,740 Dimetapp users. Check the latest studies of Dimetapp.

On Jul, 16, 2026

20 people who take Lipitor and Dimetapp together, and have interactions are studied.

What are the common drug interactions of Lipitor and Dimetapp, by gender? *:

female:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Drug hypersensitivity
Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate)
Back pain
Vomiting
Abdominal pain
Adverse drug reaction
Bradycardia (abnormally slow heart action)
Cardiomegaly (increased size of heart than normal)
Carotid artery stenosis (narrowing of carotid artery)

male:

Anxiety
Back pain
Nephropathy (damage to or disease of a kidney)
Pain
Pain in extremity
Renal failure (kidney dysfunction)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chronic kidney disease
Emotional distress
Gait disturbance

What are the common drug interactions of Lipitor and Dimetapp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Back pain
Chronic kidney disease
Gait disturbance
Nephrogenic anaemia (anaemia due to kidney disease)
Nephropathy (damage to or disease of a kidney)
Pain in extremity
Renal failure (kidney dysfunction)

50-59:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Vasospasm (sudden constriction of a blood vessel, reducing its diameter and flow rate)
Cardiomegaly (increased size of heart than normal)
Carotid artery stenosis (narrowing of carotid artery)
Limb injury
Arthralgia (joint pain)
Hypoaesthesia (reduced sense of touch or sensation)
Injury
Myalgia (muscle pain)
Pain in limb

60+:

Drug hypersensitivity
Back pain
Infection
Lung disorder (lung disease)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Pleural effusion (water on the lungs)
Pneumonia
Pyrexia (fever)
Sinus congestion (blockage of sinus)

What are the existing conditions these people have? *

Nasopharyngitis (inflammation of the nasopharynx): 2 people, 10.00%
Hypergammaglobulinaemia (elevated levels of gamma globulin): 2 people, 10.00%
Skin Disorder (skin disease): 1 person, 5.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
Cardiac Disorder: 1 person, 5.00%
Depression: 1 person, 5.00%
Eye Disorder: 1 person, 5.00%
Eye Infection: 1 person, 5.00%
Fever: 1 person, 5.00%
Gastric Ph Decreased: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Dimetapp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously